While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.
I added to my stake in UniQure and initiated a new position in Lexicon Pharmaceuticals.
Are traders working this holiday shortened week? You bet they are.
Ocular Therapeutix and TG Therapeutics are still promising companies, but their recent runs higher make them pricey at this point.
Plus, Coinbase files for an eventual initial public offering that should draw a ton of interest.
Dealmaking is going strong and looks set to continue as mental health becomes a key investment theme going forward.
Let's check out the charts of this biotech name.
BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.
Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).
The sooner that we get jabbed the more likely the economy can spring back to life.